GlassScriptPhysician profile
Jacob Taylor
NPI 1740714591
$44,657.80
in general payments reported to CMS, 2019-2025
36 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.99 · 2022: $12K · 2023: $13K · 2024: $2,804 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $7,236 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,380 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,721.25 |
| Food and Beverage | $7,236.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,380.00 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $22,500.00 | 2022-2023 | |
| Janssen Biotech, INC. | $10,081.36 | 2024-2025 | Carvykti, Rybrevant, Erleada |
| Astrazeneca Pharmaceuticals LP | $3,231.53 | 2022-2025 | Imfinzi, Lynparza |
| Edap Technomed INC | $1,822.50 | 2024-2025 | |
| Intuitive Surgical, INC. | $1,742.93 | 2025 | |
| Janssen Scientific Affairs, LLC | $1,282.58 | 2025 | |
| Boston Scientific Corporation | $430.38 | 2021-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $368.49 | 2023 | Prolaris |
| Immunitybio, INC. | $313.13 | 2024-2025 | |
| Medtronic, INC. | $275.28 | 2023-2025 | Interstim, Ligasure |
| Novartis Pharmaceuticals Corporation | $243.14 | 2023-2025 | |
| Tempus Ai, INC | $235.60 | 2024-2025 | Xt Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $216.62 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $209.16 | 2024-2025 | Orgovyx, Gemtesa |
| Dilon Technologies, INC. | $197.89 | 2023 | Hemoblast Bellows |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $186.31 | 2024-2025 | Barrigel |
| Ferring Pharmaceuticals INC. | $132.91 | 2025 | Adstiladrin |
| Aveo Pharmaceuticals, INC. | $131.50 | 2023 | Fotivda |
| Dendreon Pharmaceuticals LLC | $127.26 | 2024-2025 | Provenge |
| Profound Medical Corp. | $109.49 | 2022 | |
| Merck Sharp & Dohme LLC | $105.62 | 2025 | Lynparza, Keytruda, Keytruda Qlex |
| Foundation Medicine, INC. | $105.44 | 2023 | |
| Innovation Technologies INC | $102.75 | 2024-2025 | Irrisept |
| Blue Earth Diagnostics | $100.00 | 2024 | |
| Emd Serono, INC. | $94.90 | 2023 | Bavencio |
| Olympus America INC. | $65.56 | 2024-2025 | Itind System |
| Astellas Pharma US INC | $45.49 | 2025 | Xtandi |
| Accord Healthcare, INC. | $39.09 | 2024-2025 | |
| Urogen Pharma, INC. | $33.02 | 2024-2025 | |
| Civco Medical Instruments | $25.25 | 2024 | |
| Telix Pharmaceuticals | $24.90 | 2024 | Illuccix |
| Abbvie INC. | $19.38 | 2025 | |
| Procept Biorobotics Corporation | $16.91 | 2024 | Aquabeam System |
| Verity Pharmaceuticals INC. | $15.71 | 2025 | Trelstar |
| Bioprotect Medical, INC. | $13.99 | 2024 | Bioprotect Balloon Implant System |
| Ethicon US, LLC | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.